ALNY
Alnylam Pharmaceuticals
PEG ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: ALNY
- PEG Ratio
As of Nov 13, 2026, ALNY's PEG ratio of 0 reflects its valuation relative to its growth rate. This result reflects a P/E ratio of 8.1 measured against EPS growth of 2189.9%. When benchmarked against the trailing 4-quarter average of 0.28, ALNY's PEG ratio reflects a 100% decrease.
ALNY PEG ratio history
Alnylam Pharmaceuticals's two years historical PEG ratio averages out to 0.99. Compared to historical data, ALNY's 0.0 PEG ratio represents a decrease of 100%. ALNY hit its maximum PEG ratio of 3.82 during the Sep 2025 quarter over the last two years. The Sep 2026 quarter marked the lowest reading at 0.01, indicating the most attractive growth-adjusted valuation.
Alnylam Pharmaceuticals PEG ratio by year
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | 0.79 | 166.38 | 209.6% |
| 2024 | N/A | N/A | 38.1% |
| 2023 | N/A | N/A | 62.2% |
| 2022 | N/A | N/A | -29.2% |
| 2021 | N/A | N/A | 3.5% |
| 2020 | N/A | N/A | 8% |
| 2019 | N/A | N/A | -7.1% |
| 2018 | N/A | N/A | -39.7% |
| 2017 | N/A | N/A | -13.2% |
| 2016 | N/A | N/A | -38.8% |
| 2015 | N/A | N/A | 28.9% |
| 2014 | N/A | N/A | -234.5% |
| 2013 | N/A | N/A | 31.3% |
| 2012 | N/A | N/A | -55.1% |
| 2011 | N/A | N/A | -30.8% |
Alnylam Pharmaceuticals PEG ratio by quarter (TTM)
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Sep 2026 | 0.01 | 12.11 | 2,189.9% |
| Jun 2026 | 0.12 | 46.89 | 390.5% |
| Mar 2026 | 0.2 | 71.31 | 359.2% |
| Dec 2025 | 0.79 | 166.38 | 209.6% |
| Sep 2025 | 3.82 | 512.36 | 134.1% |
| Jun 2025 | N/A | N/A | -294.6% |
| Mar 2025 | N/A | N/A | 32.2% |
| Dec 2024 | N/A | N/A | 38.1% |
| Sep 2024 | N/A | N/A | 36.5% |
| Jun 2024 | N/A | N/A | 93.5% |
| Mar 2024 | N/A | N/A | 69.6% |
| Dec 2023 | N/A | N/A | 62.2% |
| Sep 2023 | N/A | N/A | 57.9% |
| Jun 2023 | N/A | N/A | -5.4% |
| Mar 2023 | N/A | N/A | -16% |
ALNY average PEG ratio chart
Measured against past performance, ALNY's PEG ratio comes in under the 3, 5 and 10-year averages.
PEG comparison
ALNY EPS growth
ALNY Price vs fair value
ALNY PEG vs peers
Frequently asked questions
What is Alnylam Pharmaceuticals's PEG ratio?
ALNY has a PEG ratio of 0, per Nov 13, 2026 data.
What is the 3-year average PEG ratio for Alnylam Pharmaceuticals (ALNY)?
Across the past 3 years, ALNY's PEG ratio has centered around 0.99.
What is the 5-year average PEG ratio for Alnylam Pharmaceuticals (ALNY)?
Across the past 5 years, ALNY's PEG ratio has centered around 0.99.
What is the highest PEG ratio for ALNY?
The Sep 2025 quarter marked the two years high at 3.82 for ALNY's PEG ratio.
How does the current PEG ratio for ALNY compare to its historical average?
At present, ALNY's PEG ratio runs 100% lower than its 2-year historical average.
Why is Alnylam Pharmaceuticals's PEG ratio so low?
At 0, ALNY's PEG ratio suggests the stock may be undervalued given its growth rate.
How is ALNY's PEG ratio calculated (Alnylam Pharmaceuticals PEG ratio formula)?
The PEG ratio derives from taking PE and dividing by the rate at which earnings are growing (YoY TTM). As of Nov 13, 2026, Alnylam Pharmaceuticals carries a PE ratio of 8.1. Earnings grew at 2189.9% over the TTM period ending Sep 2026. Applying the formula, this yields a PEG ratio of 0. PEG RATIO(0) = PE RATIO(8.1) / EPS GROWTH(2189.9%)
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.